Imprimis Pharmaceuticals Story Overview

IMMY -- USA Stock  

USD 2.78  0.02  0.71%

Macroaxis does not monitor all media channels or aggregates social signals for Imprimis Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Imprimis Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Imprimis Pharmaceuticals. Please also check Imprimis Pharmaceuticals Hype Analysis, Imprimis Pharmaceuticals Correlation and Imprimis Pharmaceuticals Performance.
Should You Be Concerned About Imprimis Pharmaceuticals Incs Shareholders
Simply Wall StFull coverage

Read More...   

Story Momentum

This media report from simplywall.st distributed on March 8, 2018 was a factor to the next trading day price decrease.The trading delta at closing time against the next closing price was 5.24% . The trading delta at closing time when the story was published against the current closing price is 32.86% .

Similar stores for Imprimis Pharmaceuticals

over a week ago at http://thewellesleysnews.com 
Analyst Research and Ratings Cardiovascular Systems, Inc. , Imprimis Pharmaceuticals, Inc.
news
Analyst JournalFull coverage
over three weeks ago at http://flecha123.com 
Analysts See 0.79 EPS for KB Home Imprimis Pharmaceuticals s Sentiment Is 0.88
news
Flecha 123 Homebuilders slip for second day after pending home sales fall Seeking AlphaFull coverage
over a month ago at http://reagentsglobalmarket.com 
Valuation Today Imprimis Pharmaceuticals
news
Reagents Global MarketFull coverage
over a month ago at http://www.whatsonthorold.com 
Imprimis Pharmaceuticals Inc Institutional Investors Sentiment
news
Thorold NewsImprimis Pharmaceuticals Inc Sentiment Worsens in Q1 2018 Florida Recorder Institutional Investor Sentiment About Imprimis Pharmaceuticals Inc Up The Casual SmartFull coverage
over a month ago at http://tremontherald.com 
Imprimis Pharmaceuticals, Inc. s Stock Volatility Tilts The Target Weight to 2.26
news
Tremont HeraldFull coverage
over a month ago at http://ztribune.com 
0.06 EPS Expected for FARO Technologies, Inc. Shorts at Imprimis Pharmaceuticals Lowered By 9.42
news
Z TribuneFull coverage
over two months ago at http://cardinalweekly.com 
CM Seven Star Acquisition Is At 9.90 Formed Wedge Imprimis Pharmaceuticals s Sentiment Is 0.88
news
The Cardinal Weekly Full coverage
over two months ago at http://dunlappost.com 
Sizing Up Imprimis Pharmaceuticals, Inc. as Cash Flow Moves -0.55111
news
Dunlap PostFull coverage
over two months ago at http://hillaryhq.com 
Sanmina EPS Estimated At 0.42 Imprimis Pharmaceuticals s Sentiment Is 0.88
news
Hillary HQ Full coverage
over two months ago at http://southernconservativedaily.com 
Acquisition by Robert Kammer of 34091 shares of Imprimis Pharmaceuticals subject to Rule 16b-3
news
Filed transaction by Imprimis Pharmaceuticals director. Grant, award or other acquisition pursuant to Rule 16b-3
over two months ago at http://weeklyhub.com 
Does This Provide a Reason to Buy Imprimis Pharmaceuticals, Inc. The Stock Has Formed Double Top Chart ...
news
WeeklyHubFull coverage
over three months ago at http://www.stockquote.review 
Imprimis Pharmaceuticals, Inc. Stock in Featured Spotlight
news
StockQuote Full coverage

Working Capital

Working Capital Comparative Analysis

  Working Capital 
      Imprimis Pharmaceuticals Comparables 
Imprimis Pharmaceuticals is currently under evaluation in working capital category among related companies. Working Capital is measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Peers

Imprimis Pharmaceuticals Related Equities

EPIX  17.98 %   
0%
100.0%
DRRX  2.80 %   
0%
15.0%
FLXN  2.39 %   
0%
13.0%
EOLS  1.01 %   
0%
5.0%
EVOK  0.63 %   
0%
3.0%
AGN  0.63 %   
0%
3.0%
FCSC  1.37 %   
7.0%
0%
ENDP  1.41 %   
7.0%
0%
EGRX  2.35 %   
13.0%
0%
DPLO  2.54 %   
14.0%
0%
Please also check Imprimis Pharmaceuticals Hype Analysis, Imprimis Pharmaceuticals Correlation and Imprimis Pharmaceuticals Performance. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.
Search macroaxis.com